메뉴 건너뛰기




Volumn 61, Issue 5, 2003, Pages 704-706

Psychiatric adverse events during levetiracetam therapy

Author keywords

[No Author keywords available]

Indexed keywords

ETIRACETAM; LAMOTRIGINE; PLACEBO;

EID: 0042836602     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000078031.32904.0D     Document Type: Article
Times cited : (225)

References (10)
  • 1
    • 0035655764 scopus 로고    scopus 로고
    • Pyrrolidone derivatives
    • Shorvon S. Pyrrolidone derivatives. Lancet 2001;358:1885-1892.
    • (2001) Lancet , vol.358 , pp. 1885-1892
    • Shorvon, S.1
  • 2
    • 0034768383 scopus 로고    scopus 로고
    • A systematic review of safety profile of levetiracetam: A new antiepileptic drug
    • French J, Edrich P, Cramer JA. A systematic review of safety profile of levetiracetam: a new antiepileptic drug. Epilepsy Res 2001;47:77-90.
    • (2001) Epilepsy Res , vol.47 , pp. 77-90
    • French, J.1    Edrich, P.2    Cramer, J.A.3
  • 3
    • 0010999115 scopus 로고    scopus 로고
    • Behavioral changes associated with levetiracetam use in patients with epilepsy
    • Abstract
    • Asconapè JJ, Gerardot JM, Da Costa G. Behavioral changes associated with levetiracetam use in patients with epilepsy. Epilepsia 2001;42(suppl 7):299. Abstract.
    • (2001) Epilepsia , vol.42 , Issue.SUPPL. 7 , pp. 299
    • Asconapè, J.J.1    Gerardot, J.M.2    Da Costa, G.3
  • 5
    • 0024317220 scopus 로고
    • Proposal for a revised classification of epilepsies and epileptic syndromes
    • Commission on Classification and Terminology of the International League Against Epilepsy. Proposal for a revised classification of epilepsies and epileptic syndromes. Epilepsia 1989;30:389-399.
    • (1989) Epilepsia , vol.30 , pp. 389-399
  • 6
    • 0033765115 scopus 로고    scopus 로고
    • Efficacy and tolerability of 1000-4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy
    • Grant R, Shorvon SD. Efficacy and tolerability of 1000-4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy. Epilepsy Res 2000;42:89-95.
    • (2000) Epilepsy Res , vol.42 , pp. 89-95
    • Grant, R.1    Shorvon, S.D.2
  • 7
  • 8
    • 0036724573 scopus 로고    scopus 로고
    • Disease modification in partial epilepsy
    • Walker MC, White HS, Sander JW. Disease modification in partial epilepsy. Brain 2002;125:1937-1950.
    • (2002) Brain , vol.125 , pp. 1937-1950
    • Walker, M.C.1    White, H.S.2    Sander, J.W.3
  • 9
    • 0035954353 scopus 로고    scopus 로고
    • Long-term continuation of levetiracetam in patients with refractory epilepsy
    • Krakow K, Walker M, Otoul C, Sander JW. Long-term continuation of levetiracetam in patients with refractory epilepsy. Neurology 2001;56:1772-1774.
    • (2001) Neurology , vol.56 , pp. 1772-1774
    • Krakow, K.1    Walker, M.2    Otoul, C.3    Sander, J.W.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.